Связь полиморфизма генов-супрессоров опухолей с развитием спорадической формы рака молочной железы у женщин

Список литературы

1. Аксель Е.М. Статистика рака молочной железы: заболеваемость и смертность. Книга «Рак молочной железы» Под ред. Кушлинского Н. Е., Портного СМ., Лактионова П. К. М.: Издательство РАМП. 2005. 480
2. Баранова А.В., Янковский П. К. Гены-супрессоры опухолевого роста. Молекулярная биология. 1998. Т. 32. 206−218.
3. Гарькавцева Р.Ф. Клиническая генетика и медико-генетическое консультирование в онкологии Вестник Московского онкологического общества. 2005. № 2. 2−3.
4. Гарькавцева Р.Ф., Гарькавцев И. В. Вестник РАМП. 1999. №.2. 38−44.
5. Киселев Ф.Л. Гены стабилизации ДНК и канцерогенез Молекулярная биология. 1998. Т. 32. N22. 197−205.
6. Коннин Б.П. Мишени действия онкогенов и опухолевых сунрессоров: ключ к пониманию базовых механизмов канцерогенеза Биохимия. 2000. Т. 65. 5−33.
7. Маниатис Т., Фрич Э., Сэмбрук Дж. Молекулярное клонирование М.: Изд-во «Мир». 1984. 480.
8. Тарасов В.А. Молекулярные механизмы репарации и мутагенеза М.: Изд-во «Паука». 1982. 226.
9. ApreIikova O.N., Fang B.S., Meissner E.G., Cotter S., Campbell M., Kuthiala A., Bessho M., Jensen R.A., Liu E.T. BRCAl-associated growth arrest is RB-dependent Proc Natl Acad Sci U S A 1999. V. 96. P. 11 866−11 871.
10. Armitage P, Doll R. A two-stage theory of carcinogenesis in relation to the age distribution of human cancer Br J Cancer. 1957. V. 11. P. 161 169.
11. Athma P., Rappaport R., Swift M. Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer Cancer Genet Cytogenet. 1996. V. 92. P. 130−134. 98
12. Baldeyron C Jacquemin E., Smith J., Jacquemont C De Oliveira I., Gad S., Feunteun J., Stoppa-Lyonnet D., Papadopoulo D. A single mutated BRCAl allele leads to impaired fidelity of double strand break endjoining// Oncogene. 2002. V. 21. P. 1401−1410.
13. Bemstein C, Bernstein H., Payne СМ., Garewal H. DNA repair/proapoptotic dual-role proteins in five major DNA repair pathviays: fail-safe protection against carcinogenesis Mutat. Res. 2002. V. 511. P. 145−178.
14. Bertrand P., Saintigny Y., Lopez B.S. p53s double life: transactivationindependent repression of homologous recombination Trends Genet. 2004. V. 20. P. 235−243.
15. Blume-Jensen P., Hunter T. Oncogenic kinase signaling Nature. 2001. V. 411. P. 355−365.
16. Bochar D.A., Wang L., Beniya H., Kinev A., Xue Y., Lane W.S., Wang W., Kashanchi F., Shiekhattar R. BRCAl is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer Cell. 2000. V. 102. P. 257−265. 99
17. Boice J.D., Monson R.R. Breast cancer in women after repeated fluoroscopic examinations of the chest J. Natl. Cancer. Inst. 1977. V. 59. P. 823−832.
18. Bostwick D.G., Burke H.B., Djakiew D., Euling S., Ho S.M., Landolph J., Morrison H., Sonawane В., Shifflett Т., Waters D.J., Timms B. Human prostate cancer risk factors Cancer. 2004. V. 101. P. 2371−2490.
19. Brennan P. Gene-environment interaction and aetiology of cancer: what does it mean and how can we measure it? Carcinogenesis. 2002. V. 23. P. 381−387. 3O. Bridges B.A., Arlett C.F. Risk of breast cancer in ataxia-telangiectasia NEnglJMed. 1992. V. 326. P. 1357.
20. Brodie S.G., Xu X., Qiao W., Li W.M., Cao L., Deng C.X. Multiple genetic changes are associated with mammary tumorigenesis in Brcal conditional knockout mice Oncogene. 2001. V.20. P. 7514−7523.
21. Bronner C.E., Baker S.M., Morrison P.T., Warren G., Smith L.G., Lescoe M.K., Kane M., Earabino C Lipford J., Lindblom A., et al. Mutation in the DNA mismatch repair gene homologue hMLHl is associated with hereditary non-polyposis colon cancer Nature. 1994. V. 368. P. 258 261.
22. Brose M.S., Rebbeck T.R., Calzone K.A., Stopfer J.E., Nathanson K.L., Weber B.L. Cancer risk estimates for BRCAl mutation carriers identified in a risk evaluation program J Natl Cancer Inst. 2002. V. 94. P. 13 651 372.
23. Buettner V.L., Hill K.A., Nishino H., Schaid D.J., Frisk C.S., Sommer S.S. Increased mutation frequency and altered spectrum in one of four thymic lymphomas derived from tumor prone p53/Big Blue double transgenic mice Oncogene. 1996. V. 13. P. 2407−2413. 100
24. Caims J. The origin of human cancers Nature. 1981. V. 289. P. 353 357.
25. Cantor S., Drapkin R., Zhang F., Lin Y., Han J., Pamidi S., Livingston D.M. The BRCAl-associated protein BACHl is a DNA helicase targeted by clinically relevant inactivating mutations Proc Natl Acad Sci U S A 2004. V. 101. P. 2357−2362.
26. Castilla L.H., Couch F. J., Erdos M.R., Hoskins K.F., Calzone K., Garber J.E., Boyd J., Lubin M.B., Deshano M.L., Brody L.C., Collins F.S. Weber B.L. Mutations in the BRCAl gene in families with early-onset breast and ovarian cancer Nature Genet. 1994. V. 8. P. 387−391.
27. Chano Т., Kontani K., Teramoto K., Okabe H., Ikegawa S. Truncating mutations of RBICCI in human breast cancer Nat Genet. 2002. V. 31. P. 285−288. 4O. Chen J., Silver D.P., Walpita D., Cantor S.B., Gazdar A.F., Tomlinson G., Couch F.J., Weber B.L., Ashley Т., Livingston D.M., Scully R. Stable interaction between the products of the BRCAl and BRCA2 tumor suppressor genes in mitotic and meiotic cells Molec. Cell. 1998. V. 2. P. 317−328.
28. Chen P.L., Chen C.F., Chen Y., Xiao J., Shaф Z.D., Lee W.H. The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment Proc. Natl. Acad. Sci. USA. 1998. V. 95. P. 5287−5292.
29. Chen Y., Lee W.H., Chew H.K. Emerging roles of BRCAl in transcriptional regulation and DNA repair J Cell Physiol. 1999. V. 181. P. 385−392. 101
30. Claus E.B., Risch N., Thompson W.D. Genetic analysis of breast cancer in the cancer and steroid hormone study Am J Hum Genet. 1991. V. 48. P. 232−42.
31. Cleaver J.E. Defective repair replication of DNA in xeroderma pigmentosum//Nature. 1968. V. 218. P. 652−656.
32. Cleaver J.E. Cancer in xeroderma pigmentosum and related disorders of DNA repair Nat Rev Cancer. 2005. V. 5. P. 564−573.
33. Collins C Rommens J.M., Kowbel D., Godfrey Т., Tanner M., Hwang S.I., Polikoff D., Nonet G., Cochran J., Myambo K., Jay K.E., Froula J., Cloutier Т., Kuo W.L., Yaswen P., Dairkee S., Giovanola J., Hutchinson G.B., Isola J., Kallioniemi O.P., Palazzolo M., Martin C Ericsson C Pinkel D., Albertson D., Li W.B., Gray J.W. Positional cloning of ZNF217 and NABCl: genes amplified at 20ql3.2 and overexpressed in breast carcinoma Proc Natl Acad Sci U S A 1998. V. 95. P. 8703−8708.
34. Comelis R.S., Neuhausen S.L., Johansson O., Arason A., Kelsell D., Ponder B.A., Tonin P., Hamann U., Lindblom A., Lalle P., et al. High allele loss rates at 17ql2-q21 in breast and ovarian tumors from BRCAllinked families. The Breast Cancer Linkage Consortium Genes Chromosomes Cancer. 1995. V. 13. P. 203−210.
35. Cory S. Regulation of lymphocyte survival by the bcl-2 gene family AnnuRev Immunol. 1995. V. 13. P. 513−543. 102
36. Cybulski C, Huzarski Т., Gorski В., Masojc В., Mierzejewski M., Debniak Т., Gliniewicz В., Matyjasik J., ZIowocka E., Kurzawski G., Sikorski A., Posmyk M., Szwiec M., Czajka R., Narod S.A., Lubinski J. A novel founder CtffiK2 mutation is associated with increased prostate cancer risk Cancer Res. 2004. V. 64. P. 2677−2679.
37. Dasika G.K., Lin S. C, Zhao S., Sung P., Tomkinson A., Lee E.Y. DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis Oncogene. 1999. V. 18. P. 7883−7899.
38. David-Beabes G. L., London S. J. Genetic polymorphism of XRCCl and lung cancer risk among African-Americans and Caucasians Lung Cancer. 2001. V. 34. P. 333−339.
39. Davidoff A.M., Humphrey P.A., Iglehart J.D., Marks J.R. Genetic basis for p53 overexpression in human breast cancer Proc Natl Acad Sci U S A. 1991. V. 88. P. 5006−5010.
40. Deligezer U., Dalay N. Association of the XRCCl gene polymorphisms with cancer risk in Turkish breast cancer patients Exp Mol Med. 2004. V. 36. P. 572−575.
41. Deng e x Roles of BRCAl in centrosome duplication Oncogene. 2002. V. 21. P. 6222−6227.
42. Deng e x Brodie S.G. Roles of BRCAl and its interacting proteins Bioessays. 2000. V. 22. P. 728−737. 6O. Deng e x Wang R.H. Roles of BRCAl in DNA damage repair: a link between development and cancer Hum Mol Genet. 2003. V. 12. P. R113-R123. 103
43. Durocher F, Shattuck-Eidens D., McClure M, Labrie F., Skolnick M, H, Goldgar D, E, Simard J, Comparison of BRCAl poIymoфhisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populations Hum Mol Genet, 1996, V, 5, P, 835 842, 104
44. Eshleman J.R., Markowitz S.D. Microsatellite instability in inherited and sporadic neoplasms Curr Opin Oncol. 1995. V. 7. P. 83−89.
45. Etzel С J., Amos C.I., Spitz M.R. Risk for smoking-related cancer among relatives of lung cancer patients Cancer Res. 2003. V. 63. P. 8531−8535.
46. Evans D.G., Neuhausen S.L., Bulman M., Young K., Gokhale D., Lalloo F. Haplotype and cancer risk analysis of two common mutations, BRCAl 4184del4 and BRCA2 2157delG, in high risk northwest England breast/ovarian families J Med Genet. 2004. V. 41. P. e21.
47. Evans S.C., Mims В., McMasters K.M., Foster C. J, deAndrade M., Amos C.I., Strong L.C., Lozano G. Exclusion of a p53 germline mutation in a classic Li-Fraumeni syndrome family Hum Genet. 1998. V. 102. P. 681−686.
48. Fackenthal J.D., Marsh D.J., Richardson A.L., Cummings S.A., Eng C Robinson B.G., Olopade O.I. Male breast cancer in Cowden syndrome patients with germline PTEN mutations J Med Genet. 2001. V. 38. P. 159−164. 76. Fan R., Wu M.T., Miller D., Wain J.C., Kelsey K.T., Wiencke J.K., Christiani D.C. The p53 codon 72 polymorphism and lung cancer risk Cancer Epidemiol Biomarkers Prev. 2000. V. 9. P. 1037−1042. 105
49. Fearon E.R. Human cancer syndromes: clues to the origin and nature of cancer Science. 1997. V. 278. P. 1043−1050. 8O. Fisher J.C. Multiple-mutation theory of carcinogenesis Nature. 1958. V. 181. P. 651−652.
50. Fodor F.H., Weston A., Bleiweiss I.J., McCurdy L.D., Walsh M.M., Tartter P.I., Brower S.T., Eng CM Frequency and carrier risk associated with common BRCAl and BRCA2 mutations in Ashkenazi Jewish breast cancer patients Am J Hum Genet. 1998. V. 63. P. 45−51.
51. Foray N., Randrianarison V., Marot D., Perricaudet M., Lenoir G., Feunteun J. Gamma-rays-induced death of human cells carrying mutations of BRCAl or BRCA2 Oncogene. 1999. V. 18. P. 7334−7342.
52. Ford D., Easton D.F., Peto J. Estimates of the gene frequency of BRCAl and its contribution to breast and ovarian cancer incidence Am J Hum Genet. 1995. V. 57. P. 1457−1462.
53. Ford D., Easton D.F., Stratton M., Narod S., Goldgar D., Devilee P., Bishop D.T., Weber В., Lenoir G., Chang-Claude J., Sobol H., Teare M.D., Struewing J., Arason A., Schemeck S., Peto J., Rebbeck T.R., Tonin P., Neuhausen S., Barkardottir R., Eyfjord J., Lynch H., Ponder B.A., Gayther S.A., Zelada-Hedman M., et al. Genetic Heterogeneity and Penetrance Analysis of the BRCAl and BRCA2 Genes in Breast Cancer Families Am. J. Hum. Genet. 1998. V. 62. P. 676−689. 106
54. Freedman M.L., Penney K.L., Stram D.O., Riley S., McKean-Cowdin R., Le Marchand L, Altshuler D., Haiman C.A. A haplotype-based casecontrol study of BRCAl and sporadic breast cancer risk Cancer Res. 2005. V. 65. P. 7516−7522.
55. Futreal P.A., Coin L., Marshall M., Down Т., Hubbard Т., Wooster R., Rahman N., Stratton M.R. A census of human cancer genes Nat Rev Cancer. 2004. V. 4. P. 177−183. 90. Gao Q., Neuhausen S., Cummings S., Luce M., Olopade O. L Recurrent germ-line BRCAl mutations in extended African American families with early-onset breast cancer Am J Hum Genet. 1997. V. 60. P. 1233−1236.
56. Garcia-Closas M., Egan K.M., Newcomb P.A., Brinton L.A., TitusEmstoff L., Chanock S., Welch R., Lissowska J., Peplonska В., Szeszenia-Dabrowska N., Zatonski W., Bardin-Mikolajczak A., Struewing J.P. Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses Hum Genet. 2006. V. 119. P. 376−388. 107
57. Gayther S.A., Harrington P., Russell P., Kharkevich G., Garkavtseva R.F., Ponder B.A. Frequently occurring germ-line mutations of the BRCAl gene in ovarian cancer families from Russia Am J Hum Genet. 1997. V. 60. P. 1239−1242.
58. Gayther S.A., Mangion J., Russell P., Seal S., Barfoot R., Ponder B.A., Stratton M.R., Easton D. Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene Nat Genet. 1997. V. 15. P. 103−105.
59. Glushien A.S., Mansuy M.M., Littman D.S. Pheochromocytoma- its relationship to the neurocutaneous syndromes Am J Med. 1953. V. I4. P. 318−327.
60. Goldar D.E., Reilly P.R. A common BRCAl mutation in the Ashkenazim Nature Genetics. 1995. V. 11. P. 113−114.
61. Goode E.L., Ulrich C.M., Potter J.D. Polymoфhisms in DNA repair genes and associations with cancer risk Cancer Epidemiol Biomarkers Prev.2002.V. 11. P. 1513−1530.
62. Gorlin R.J., Sedano H.O. The multiple nevoid basal cell carcinoma syndrome revisited //Birth Defects Orig Artie Ser. 1971. V.7. P. 140−148.
63. Gorski В., Byrski Т., Huzarski Т., Jakubowska A., Menkiszak J., Gronwald J., Pluzanska A., Bebenek M., Fischer-Maliszewska L., Grzybowska E., Narod S.A., Lubinski J. Founder mutations in the BRCAl gene in Polish families with breast-ovarian cancer Am. J. Hum. Genet. 2000. V. 66. P. 1963−1968.
64. Gorski В., Narod S.A., Lubinski J. A common missense variant in BRCA2 predisposes to early onset breast cancer Breast Cancer Res. 2005.V. 7.P.R1023-R1027. 108
65. Gowen L.C., Avrutskaya A.V., Latour A.M., Koller B.H., Leadon S.A. BRCAl required for transcription-coupled repair of oxidative DNA damage Science. 1998. V. 281. P. 1009−1012.
66. Gowen L.C., Avrutskaya A.V., Latour A.M., Koller B.H., Leadon S.A. Retraction (Letter) Science. 2003. V. 300. P. 1657.
67. Groden J., Thliveris A., Samowitz W., Carlson M., Gelbert L., Albertsen H., Joslyn G., Stevens J., Spirio L., Robertson M., et al. Identification and characterization of the familial adenomatous polyposis coli gene Cell. 1991. V. 66. P. 589−600.
68. Hakansson S., Johannsson 0., Johansson U., Sellberg G., Loman N., Gerdes A.M., Holmberg E., Dahl N., Pandis N., Kristoffersson U., Olsson H., Borg A. Moderate frequency of BRCAl and BRCA2 germ-line mutations in Scandinavian familial breast cancer Am J Hum Genet. 1997. V. 60. P. 1068−1078.
69. Hakem R., Мак T.W. Animal models of tumor-suppressor genes Annu Rev Genet. 2001. V. 35. P. 209- 24L
70. Haluska F.G., Tsujimoto Y., Croce C. M. Mechanisms of chromosome translocation in B- and T-cell neoplasia Trends Genet. 1987. V.3. P. 11−15.
71. Hamann U., Haner M., Stosiek U., Bastert G., Scott R.J. Low frequency of BRCAl germline mutations in 45 German breast/ovarian cancer families J. Med. Genet. 1997. V. 34. P. 884−888. 109. Han D.F., Zhou X., Hu M.B., Wang C.H., Xie W., Tan X.D., Zheng F., Liu F. Sulfotransferase 1 Al (SULTlAl) polymorphism and breast cancer risk in Chinese women Toxicol Lett. 2004. V. 150. P. 167−177.
72. Harfe B.D., Jinks-Robertson S. DNA mismatch repair and genetic instability A. Rev. Genet. 2000. V. 34. P. 359−399. 109
73. Hartman A.R., Ford J.M. BRCAl induces DNA damage recognition factors and enhances nucleotide excision repair Nat Genet. 2002.V. 32. P. 180−184.
74. Harwood J., Tachibana A., Meuth M. Multiple dispersed spontaneous mutations: a novel pathway of mutation in a malignant human cell line//Mol Cell Biol. 1991. V. 11. P. 3163−3170.
75. Healey C.S., Dunning A.M., Teare M.D., Chase D., Parker L., Bum J., Chang-Claude J., Mannermaa A., Kataja V., Huntsman D.G., Pharoah P.D., Luben R.N., Easton D.F., Ponder B.A. A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability Nat. Genet. 2000. V. 26. P. 362−364.
76. Hein D.W., Doll M.A., Fretland A.J., Leff M.A., Webb S.J., Xiao G.H., Devanaboyina U.S., Nangju N.A., Feng Y. Molecular genetics and epidemiology of the NATl and NAT2 acetylation polymorphisms Cancer Epidemiol Biomarkers Prev. 2000. V. 9. P. 29−42.
77. Helzlsouer K.J., Selmin O., Huang H.Y., Strickland P.T., Hoffman S., Alberg A.J., Watson M., Comstock G.W., Bell D. Association between glutathione S-transferase Ml, PI, and Tl genetic polymorphisms and development of breast cancer J Natl Cancer Inst. 1998. V. 90. P. 512 518.
78. Hollander M.C., Sheikh M.S., Bulavin D.V., Lundgren K., Augeri- Henmueller L., Shehee R., Molinaro T.A., Kim K.E., Tolosa E., Ashwell J.D., Rosenberg M.P., Zhan Q., Femandez-Salguero P.M., Morgan W.F., Deng e x Fomace AJ. Jr. Genomic instability in Gadd45a-deficient mice//Nat Genet. 1999. V. 23. P. 176−184. 110
79. Howlett N.G., Taniguchi Т., Olson S., Cox В., Waisfisz Q., De Die- Smulders C, Persky N., Grompe M., Joenje H., Pals G., Ikeda H., Fox E.A., DAndrea A.D. Biallelic inactivation of BRCA2 in Fanconi anemia Science. 2002. V. 297. P. 606−609.
80. Hsieh F.I., Pu Y.S., Chem H.D., Hsu L.I., Chiou H.Y., Chen C.J. Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer//BrJ Cancer. 1999. V. 81. P. 537−541. 121. Hsu L.C., Doan T.P., White R.L. Identification of a gamma-tubulin- binding domain inBRCAl //CancerRes. 2001. V. 61. P. 7713−7718. 122. Hsu L.C., White R.L. BRCAl is associated with the centrosome during mitosis Proc Natl Acad Sci U S A 1998. V. 95. P. 12 983−12 988.
81. Ionov Y., Peinado M.A., Malkhosyan S., Shibata D., Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis Nature. 1993. V. 363. P. 558 561.
82. Ishitobi M., Miyoshi Y., Ando A., Hasegawa S., Egawa C Tamaki Y., Monden M., Noguchi S. Association of BRCA2 polymorphism at codon 784 (Met/Val) with breast cancer risk and prognosis Clin Cancer Res. 2003. V. 9. P. 1376−1380.
83. Jasin M. Homologous repair of DNA damage and tumorigenesis: the BRCA connection Oncogene. 2002. V. 21. P. 8981−8993.
84. Jeggo P.A. DNA breakage and repair Adv. Genet. 1998. V. 38. P. 185−218. Ill
85. Joenje H., Patel K.J. The emerging genetic and molecular basis of Fanconi anaemia Nat Rev Genet. 2001. V. 2. P. 446−457.
86. Johannsson 0., Ostermeyer E.A., Hakansson S., Friedman L.S., Johansson U., Sellberg G., Br0ndum-Nielsen K., Sele V., Olsson H., King M.C., Borg A. Founding BRCAl mutations in hereditary breast and ovarian cancer in southern Sweden Am J Hum Genet. 1996. V. 58. P. 441−450.
87. Kadam S., Emerson B.M. Transcriptional specificity of human SWI/SNF BRGl and BRM chromatin remodeling complexes Mol Cell. 2003. V. 11. P. 377−389.
88. Karppinen S.M., Heikkinen K., Rapakko K., Winqvist R. Mutation screening of the BARDl gene: evidence for involvement of the Cys557Ser allele in hereditary susceptibility to breast cancer J Med Genet. 2004. V. 41. P. el 14.
89. Kato M., Yano K., Matsuo F., Saito H., Katagiri Т., Kurumizaka H., Yoshimoto M., Kasumi F., Akiyama F., Sakamoto G., Nagawa H., Nakamura Y., Miki Y. Identification of Rad51 alteration in patients with bilateral breast cancer J Hum Genet. 2000. V. 45. P. 133−137.
90. Kawahara M., Sakayori M., Shiraishi K., Nomizu Т., Takeda M., Abe R., Ohuchi N., Takenoshita S., Ishioka C. Identification and evaluation of 55 genetic variations in the BRCAl and the BRCA2 genes of patients from 50 Japanese breast cancer families J Hum Genet. 2004. V. 49. P. 391−395.
91. Kellogg D, R., Moritz M., Alberts B.M. The centrosome and cellular organization Annu Rev Biochem. 1994. V. 63. P. 639−674. 112
92. Kerr P., Ashworth A. New complexities for BRCAl and BRCA2 Curr Biol. 2001. V. 11. P. R668-R676.
93. Keshava C Frye B.L., Wolff M.S., McCanlies E.C., Weston A. Waf-1 (p21) and p53 polymoфhisms in breast cancer Cancer Epidemiol Biomarkers Prev. 2002. V. 11. P. 127−130.
94. Khanna K.K., Jackson S.P. DNA double-strand breaks: signaling, repair and the cancer connection Nat. Genet. 2001. V. 27. P. 247−254.
95. Knudson, A.G. Mutation and cancer: statistical study of retinoblastoma Proc Natl Acad Sci U S A. 1971. V. 68. P. 820−823.
96. Knudson A.G. Hereditary cancer, oncogenes, and antioncogenes Cancer Res. 1985. V. 45. P. 1437−1443.
97. Knudson A.G. The genetic predisposition to cancer Birth Defects Orig. Artie. Ser. 1989. V. 25. P. 15−27.
98. Knudson A.G. Antioncogenes and human cancer Proc Natl Acad Sci U S A 1993. V. 90. P. 10 914−10 921.
99. Kolodner R.D., Tytell J.D., Schmeits J.L., Kane M.F., Gupta R.D., Weger J., Wahlberg S., Fox E.A., Peel D., Ziogas A., Garber J.E., Syngal S., Anton-Culver H., Li F.P. Germ-line msh6 mutations in colorectal cancer families Cancer Res. 1999. V. 59. P. 5068−5074.
100. Korsmeyer S.J. Regulators of cell death Trends Genet. 1995. V. 11.P. 101−105.
101. Kotnis A., Sarin R., Mulherkar R. Genotype, phenotype and cancer: role of low penetrance genes and environment in tumour susceptibility J Biosci. 2005. V. 30. P. 93−102. 113
102. Lander E.S., Linton L.M., Birren В., Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, Funke R, Gage D, Harris K, Heaford A, Howland J, Kann L, Lehoczky J, LeVine R, et. al. Initial sequencing and analysis of the human genome Nature. 2001. V. 409. P. 860−921.
103. Langston A. A., Malone K.E., Thompson J.D., Daling J.R., Ostrander E.A. BRCAl mutations in a population-based sample of young women with breast cancer New Eng. J. Med. 1996. V. 334. P. 137−142.
104. Lavigne J.A., Helzlsouer K.J., Huang H.Y., Strickland P.T., Bell D.A., Selmin O., Watson M.A., Hoffman S., Comstock G.W., Yager J.D. An association between the allele coding for a low activity variant of catechol-0-methyltransferase and the risk for breast cancer Cancer Res. 1997. V. 57. P. 5493−5497.
105. Liede A., Cohen В., Black D.M., Davidson R.H., Renwick A., Hoodfar E., Olopade O. L, Micek M., Anderson V., De Mey R., Fordyce A., Warner E., Dann J.L., King M.C., Weber В., Narod S.A., Steel C M Evidence of a founder BRCAl mutation in Scotland Br J Cancer. 2000. V. 82. P. 705−711.
106. Lindblom A., Sandelin K., Iselius L., Dumanski J., White I., Nordenskjold M., Larsson C. Predisposition for breast cancer in carriers of constitutional translocation 1 lq-22q Am J Hum Genet. 1994 V. 54. P. 871−876.
107. Listgarten J., Damaraju S., Poulin В., Cook L., Dufour J., Driga A., Mackey J., Wishart D., Greiner R., Zanke B. Predictive models for breast cancer susceptibility from multiple single nucleotide polymorphisms Clin Cancer Res. 2004. V. 10. P. 2725−2737.
108. Lobaccaro J.M., Lumbroso S., Belon C Galtier-Dereure F., Bringer J., Lesimple Т., Namer M., Cutuli B.F., Pujol H., Sultan C. Androgen receptor gene mutation in male breast cancer Hum Mol Genet. 1993. V. 2. P. 1799−1802. 115
109. London S.J., Yuan J.M., Coetzee G.A., Gao Y.T., Ross R.K., Yu M, C. CYPlAl I462V genetic polymorphism and lung cancer risk in a cohort of men in Shanghai, China Cancer Epidemiol Biomarkers Prev. 2000. V. 9. P. 987−991. 162. MacLachlan Т.К., Somasundaram K., Sgagias M., Shifman Y., Muschel R.J., Cowan K.H., El-Deiry W.S. BRCAl effects on the cell cycle and the DNA damage response are linked to altered gene expression J Biol Chem. 2000. V. 275. P. 2777−2785.
110. Malkin D., Li F.P., Strong L.C., Fraumeni J.F. Jr, Nelson C.E., Kim D.H., Kassel J., Gryka M.A., Bischoff F.Z., Tainsky M.A., et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms Science. 1990. V. 250. P. 1233−1238.
111. Marth G., Yeh R., Minton M., Donaldson R., Li Q., Duan S., Davenport R., Miller R.D., Kwok P.Y. Single-nucleotide polymorphisms in the public domain: how useful are they? Nat Genet. 2001. V. 27. P. 371−372.
112. Meijers-Heijboer H., Wijnen J., Vasen H., Wasielewski M., Wagner A., Hollestelle A., Elstrodt F., van den Bos R., de Snoo A., Fat G.T., Brekelmans C, Jagmohan S., Franken P., Verkuijlen P., van den Ouweland A., Chapman P., Tops C Moslein G., Bum J., Lynch H., Klijn J., Fodde R., Schutte M. The CHEK2 1 lOOdelC mutation identifies families with a hereditary breast and colorectal cancer phenotype Am J Hum Genet. 2003. V. 72. P. 1308−1314.
113. Mellon L, Rajpal D.K., Koi M., Boland C.R., Champe G.N. Transcription-coupled repair deficiency and mutations in human mismatch repair genes Science. 1996. V. 272. P. 557−560. 116
114. Miller D.P., Liu G., De Vivo L, Lynch T.J., Wain J. C, Su L., Christiani D.C. Combinations of the variant genotypes of GSTPl, GSTMl, and p53 are associated with an increased lung cancer risk Cancer Res. 2002. V. 62. P. 2819−2823.
115. Millikan R.C., Player J.S., Decotret A.R., Tse C.K., Keku T. Polymorphisms in DNA repair genes, medical exposure to ionizing radiation, and breast cancer risk Cancer Epidemiol Biomarkers Prev. 2005. V. 14. P. 2326−2334.
116. Milner J., Ponder В., Hughes-Davies L., Seltmann M., Kouzarides T. Transcriptional activation functions in BRCA2 Nature. 1997. V. 386. P. 772−773.
117. Monteiro A.N. BRCA1: exploring the links to transcription Trends Biochem Sci. 2000. V. 25. P. 469−474.
118. Moynahan M.E., Chiu J.W., Koller B.H., Jasin M. Brcal controls homology-directed DNA repair Mol. Cell. 1999. V. 4. P. 511−518.
119. Moynahan M.E., Cui T.Y., Jasin M. Homology-directed dna repair, mitomycin-c resistance, and chromosome stability is restored with correction of a Brcal mutation Cancer Res. 2001. V. 61. P. 4 842 850.
120. Nagy R., Sweet K., Eng C. Highly penetrant hereditary cancer syndromes Oncogene. 2004. V. 23. P. 6445−6470.
121. Narod S., Tonin P., Lynch H., Watson P., Feunteun J., Lenoir G. Histology of BRCAl-associated ovarian tumours Lancet. 1994. V. 343. P. 236 only. 117
122. Nelson H. H., Kelsey K. Т., Mott L. A., Karagas M. R. The XRCC1 Arg399Gln polymorphism, sunburn, and non-melanoma skin cancer: evidence of gene-environment interaction Cancer Res. 2002. V. 62. P. 152−155.
123. Neuberger M.S., Milstein C. Somatic hypermutation Curr Opin Immunol. 1995. V. 7. P. 248−254.
124. Neuhausen S., Gilewski Т., Norton L., Tran Т., McGuire P., Swensen J., Hampel H., Borgen P., Brown K., Skolnick M., ShattuckEidens D., Jhanwar S., Goldgar D., Offit K. Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer Nat Genet. 1996. V. 13. P. 126−128.
125. Nishimoto I.N., Pinheiro N.A., Rogatto S.R., Carvalho A.L., de Moura R.P., Caballero O.L., Simpson A., Kowalski L.P. Alcohol dehydrogenase 3 genotype as a risk factor for upper aerodigestive tract cancers Arch Otolaryngol Head Neck Surg. 2004. V. 130. P. 78−82.
126. Nishino H., Knoll A., Buettner V.L., Frisk C.S., Maruta Y., Haavik J., Sommer S.S. p53 wild-type and p53 nullizygous Big Blue transgenic mice have similar frequencies and patterns of observed mutation in liver, spleen and brain Oncogene. 1995. V. 11. P. 263−270.
127. Nishisho I., Nakamura Y., Miyoshi Y., Miki Y., Ando H., Horii A., Koyama K., Utsunomiya J., Baba S., Hedge P., et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients Science. 1991. V. 253. P. 665−669. 118
128. Ohayon Т., Gershoni-Baruch R., Papa M.Z., Distelman Menachem Т., Eisenberg Barzilai S., Friedman E. The R72P P53 mutation is associated with familial breast cancer in Jewish women Br J Cancer. 2005. V. 92. P. 1144−1148.
129. Oltvai Z.N., Milliman C.L., Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death Cell. 1993. V. 74. P. 609−619.
130. Paik S. Clinical significance of erbB-2 (HER-2/neu) protein Cancer Invest. 1992. V. 10. P. 575−579.
131. Papadopoulos N., Nicolaides N.C., Wei Y.F., Ruben S.M., Carter K.C., Rosen C.A., Haseltine W.A., Fleischmann R.D., Fraser СМ., Adams M.D., et al. Mutation of a mutL homolog in hereditary colon cancer// Science. 1994. V. 263. P. 1625−1629.
132. Park J., Chen L., Tockman M.S., Elahi A., Lazarus P. The human 8- oxoguanine DNA N-glycosylase 1 (hOGGl) DNA repair enzyme and its association with lung cancer risk Pharmacogenetics. 2004. V. 4. P. 103 109.
133. Peltomaki P., Aaltonen L.A., Sistonen P., Pylkkanen L., Mecklin J.P., Jarvinen H., Green J.S., Jass J.R., Weber J.L., Leach F.S., et al. Genetic mapping of a locus predisposing to human colorectal cancer Science. 1993. V. 260. P. 810−812.
134. Peters A., Storb U. Somatic hypermutatlon of immunoglobulin genes is linked to transcription initiation Immunity. 1996. V. 4. P. 5765.
135. Peto J., Houlston R.S. Genetics and the common cancers Eur J Cancer. 2001. V. 37. P. S88-S96.
136. Petrij-Bosch A., Peelen Т., van Vliet M., van Eijk R., Olmer R., Drusedau M., Hogervorst F.B., Hageman S., Arts P.J., Ligtenberg M.J., Meijers-Heijboer H., Klijn J.G., Vasen H.F., Comelisse C.J., van t Veer L.J., Bakker E., van Ommen G.J., Devilee P. BRCAl genomic deletions are major founder mutations in Dutch breast cancer patients Nat Genet. 1997. V. 17. P. 341−345.
137. Pierce A.J., Stark J.M., Araujo F.D., Moynahan M.E., Berwick M., Jasin M. Double-strand breaks and tumorigenesis Trends. Cell Biol. 2001.V. 11. S52−59.
138. Piver M.S., Baker T.R., Jishi M.F., Sandecki A.M., Tsukada Y., Natarajan N., Mettlin C.J., Blake C.A. Familial ovarian cancer. A report of 658 families from the Gilda Radner Familial Ovarian Cancer Registry 1981−1991 //Cancer. 1993. V. 71. P. 582−588. 197.
139. Ponder B.A. Cancer genetics//Nature. 2001. V. 411. P. 336-
140. Potter J.D. Colorectal cancer: molecules and populations J Natl Cancer Inst. 1999. V. 91. P. 916−932. 120
141. Rampino N., Yamamoto H., Ionov Y., Li Y., Sawai H., Reed J. C, Perucho M. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype Science. 1997. V. 275. P. 967−969.
142. Riley E., Swift M. A family with Peutz-Jeghers syndrome and bilateral breast cancer// Cancer. 1980. V. 46. P. 815−817.
143. Risch H.A., McLaughlin J.R., Cole D.E., Rosen В., Bradley L., Kwan E., Jack E., Vesprini D.J., Kuperstein G., Abrahamson J.L., Fan I., Wong В., Narod S.A. Prevalence and penetrance of germline BRCAl and BRCA2 mutations in a population series of 649 women with ovarian cancer//Am. J. Hum. Genet. 2001. V. 68. P. 700−710. 203. Roa B.B., Boyd A.A., Volcik K., Richards C.S. Ashkenazi Jewish population frequencies for common mutations in BRCAl and BRCA2. Nat Genet. 1996. V. 14. P. 185−187.
144. Sarantaus L., Vahteristo P., Bloom E., Tamminen A., Unkila-Kallio L., Butzow R., Nevanlinna H. BRCAl and BRCA2 mutations among 233 unselected Finnish ovarian carcinoma patients Europ. J. Hum. Genet. 2001. V. 9. P. 424−430.
145. Savitsky K., Bar-Shira A., Gilad, S., Rotman G., Ziv Y., Vanagaite L., Tagle D. A., Smith S., Uziel Т., Sfez S., Ashkenazi M., Pecker I., and 18 others. A single ataxia telangiectasia gene with a product similar to PI3 kinase Science. 1995. V. 268. P. 1749−1753.
146. Schrager C.A., Schneider D., Gruener A.C., Tsou H.C., Peacocke M. Clinical and pathological features of breast disease in Cowdens syndrome: an underrecognized syndrome with an increased risk of breast cancer Hum Pathol. 1998. V. 29. P. 47−53. 121
147. Schwienbacher C Sabbioni S., Campi M., Veronese A., Bemardi G., Menegatti A., Hatada I., Mukai Т., Ohashi H., Barbanti-Brodano G., Croce СМ., Negrini M. Transcriptional map of 170-kb region at chromosome 1 Ipl5.5: identification and mutational analysis of the BWRl A gene reveals the presence of mutations in tumor samples Proc Natl Acad Sci U S A 1998. V. 95. P. 3873−3878.
148. Scully R., Anderson S.F., Chao D.M., Wei W., Ye L., Young R.A., Livingston D.M., Parvin J.D. BRCAl is a component of the RNA polymerase II holoenzyme Proc. Nat. Acad. Sci. USA. 1997. V. 94. P. 5605−5610.
149. Scully R., Chen J., Plug A., Xiao Y., Weaver D., Feunteun J., Ashley Т., Livingston D.M. Association of BRCAl with Rad51 in mitotic and meiotic cells Cell. 1997. V. 88. P. 265−275.
150. Seow A., Zhao В., Lee E.J., Poh W.T., Teh M., Eng P., Wang Y.T., Tan W.C., Lee H.P. Cytochrome P4501A2 (CYP1A2) activity and lung cancer risk: a preliminary study among Chinese women in Singapore Carcinogenesis. 2001. V. 22. P. 673−677.
151. Shen S.X., Weaver Z., Xu X., Li C Weinstein M., Chen L., Guan X.Y., Ried Т., Deng C.X. A targeted disruption of the murine Brcal gene causes gamma-irradiation hypersensitivity and genetic instability Oncogene. 1998. V. 17. P. 3115−3124.
152. Sherr C.J. Principles of tumor suppression Cell. 2004. V. 116. P. 235−246.
153. Shin K.H., Park K.H., Hong H.J., Kim J.M., Oh J.E., Choung P.H., Min B.M. Prevalence of microsatellite instability, inactivation of mismatch repair genes, p53 mutation, and human papillomavirus infection in Korean oral cancer patients Int J Oncol. 2002. V. 21. P. 297−302. 122
154. Simard J., Tonin P., Durocher F., Morgan K., Rommens J., Gingras S., Samson C Leblanc J.F., Belanger C Dion F., et al. Common origins of BRCAl mutations in Canadian breast and ovarian cancer families Nat Genet. 1994. V. 8. P. 392−398.
155. Simpson A.J. The natural somatic mutation frequency and human carcinogenesis Adv Cancer Res. 1997. V. 71. P. 209−240.
156. Slamon D.J., Godolphin W., Jones L.A., Holt J.A., Wong S.G., Keith D.E., Levin W.J., Stuart S.G., Udove J., Ullrich A., et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer Science. 1989. V. 244. P. 707−712.
157. Smith M.L., Ford J.M., Hollander M.C., Bortnick R.A., Amundson S.A., Seo Y.R., Deng C.X., Hanawalt P. C, Fomace AJ.Jr. p53-mediated DNA repair responses to UV radiation: studies of mouse cells lacking p53, p21, and/or gadd45 genes Mol Cell Biol. 2000. V. 20. P. 37 053 714.
158. Smith S.A., Baston D.F., Evans D.G. R., Ponder B.A. J. Allele losses in the region 17q 12−21 in familial breast and ovarian cancer involve the wild-type chromosome Nature Genet. 1992. V. 2. P. 128 131.
159. Smith S.M., Sorsby A. Retinoblastoma: some genetic aspects Ann. Hum. Genet. 1958. V. 23. P. 50−58.
160. Smith T.M., Lee M.K., Szabo C. L, Jerome N., McEuen M., Taylor M., Hood L., King M.C. Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCAl Genome Res. 1996. V. 6. P. 1029−1049. 123
161. Szabo C.I., King M.C. Population genetics of BRCAl and BRCA2 //Am. J. Hum. Genet. 1997. V. 60. P. 1013−1020,
162. Takimoto R., MacLachlan Т.К., Dicker D.T., Niitsu Y., Mori Т., el- Deiry W.S. BRCAl transcriptionally regulates damaged DNA binding protein (DDB2) in the DNA repair response following UV-irradiation Cancer Biol Then 2002. V. 1. P. 177−186.
163. Tavtigian S.V., Simard J., Rommens J., Couch F., Shattuck-Eidens D., Neuhausen S., Merajver S., Thorlacius S., Offit K., Stoppa-Lyonnet D., Belanger C Bell R., and 37 others. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds Nature Genet. 1996. V. 12. P. 333−337. 233. The Breast Cancer Linkage Consortium. Cancer Risks in BRCA2 Mutation Carriers J Natl Cancer Inst. 1999. V. 91. P. 1310−1316.
164. Thibodeau S.N., Bren G., Schaid D. Microsatellite instability in cancer of the proximal colon Science. 1993. V. 260. P. 816−819.
165. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression Nature Rev. Cancer. 2002. V. 2. P. 442−454.
166. Thompson D., Easton D., Breast Cancer Linkage Consortium. Variation in cancer risks, by mutation position, in BRCA2 mutation carriers Am J Hum Genet. 2001. V. 68. P. 410−419.
167. Thompson D., Easton D., Breast Cancer Linkage Consortium. Variation in BRCAl cancer risks by mutation position Cancer Epidemiol Biomarkers Prev. 2002. V. 11. P. 329−336. 125
168. Thorlacius S., Olafsdottir G., Tryggvadottir L., Neuhausen S., Jonasson J.G., Tavtigian S.V., Tulinius H., Ogmundsdottir H.M., Eyfjord J.E. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes Nat Genet. 1996. V. 13. P. 117−119.
169. Tiemersma E.W., Bunschoten A., Kok F.J., Glatt H., de Boer S.Y., Kampman E. Effect of SULTl Al and NAT2 genetic polymoфhism on the association between cigarette smoking and colorectal adenomas Int J Cancer. 2004. V. 108. P. 97−103.
170. Tomlinson I.P., Novelli M.R., Bodmer W.F. The mutation rate and cancer// Proc Natl Acad Sci U S A 1996. V. 93. P. 14 800−14 803.
171. Tonin P.N., Mes-Masson A.M., Narod S.A., Ghadirian P., Provencher D. Founder BRCAl and BRCA2 mutations in French Canadian ovarian cancer cases unselected for family history Clin Genet. 1999. V. 55. P. 318−324.
172. Tonin P., Weber В., Offit K., Couch F., Rebbeck T.R., Neuhausen S., Godwin A.K., Daly M., Wagner-Costalos J., Berman D., Grana G., Fox E., Kane M.F., Kolodner R.D., Krainer M., Haber D.A., Struewing J.P., Warner E., Rosen В., Lerman C Peshkin В., Norton L., Serova O., Foulkes W.D., Garber J.E., et al. Frequency of recurrent BRCAl and BRCA2 mutations in Ashkenazi Jewish breast cancer families Nat Med. 1996. V. 2. P. 1179−1183. 126
173. Umar A., Kunkel T.A. DNA-replication fidelity, mismatch repair and genome instability in cancer cells Eur J Biochem. 1996. V. 238. P. 297−307.
174. Varley J., Haber D.A. Familial breast cancer and the hCHK2 1 lOOdelC mutation: assessing cancer risk Breast Cancer Res. 2003. V. 5. P. 123−125.
175. Venkitaraman A.R. Cancer susceptibility and the functions of BRCAl and BRCA2 Cell. 2002. V. 108. P. 171−182.
176. Venter J. C, Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G., Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., et. al. The sequence of the human genome Science. 2001. V. 291. P. 13 041 351.
177. Vogel F. The genetics of retinoblastoma Hum. Genet. 1979. V. 52. P. 1−54.
178. Vogelstein В., Kinzler K.W. The multistep nature of cancer. Trends in Genetics. 1993. V. 9. №.4. P.138−141.
179. Wang Q., Zhang H., Kajino K., Greene M.I. BRCAl binds c-Myc and inhibits its transcriptional and transforming activity in cells Oncogene. 1998. V. 17. P. 1939−1948.
180. Wang Y., Cortez D., Yazdi P., Neff N., Elledge S.J., Qin J. BASC, a super complex of BRCAl-associated proteins involved in the recognition and repair of aberrant DNA structures Genes Dev. 2000. V. 14. P. 927−939. 127
181. Weber Т.К., Conlon W., Petrelli N.J., Rodriguez-Bigas M., Keitz В., Pazik J., Farrell C OMalley L., Oshalim M., Abdo M., Anderson G., Stoler D., Yandell D. Genomic DNA-based hMSH2 and hMLHl mutation screening in 32 Eastern United States hereditary nonpolyposis colorectal cancer pedigrees Cancer Res. 1997. V. 57. P. 3798−3803.
182. Weeda G., van Ham R.C., Vermeulen W., Bootsma D., van der Eb A.J., Hoeijmakers J.H. A presumed DNA helicase encoded by ERCC-3 is involved in the human repair disorders xeroderma pigmentosum and Cockaynes syndrome Cell. 1990. V. 62. P. 777−791.
183. Weeda G., Eveno E., Donker I., Vermeulen W., Chevallier-Lagente O., Taieb A., Stary A., Hoeijmakers J.H., Mezzina M., Sarasin A. A mutation in the XPB/ERCC3 DNA repair transcription gene, associated with trichothiodystrophy Am J Hum Genet. 1997. V. 60. P. 320−329.
184. Welcsh P.L., Lee M.K., Gonzalez-Hernandez R.M., Black D.J., Mahadevappa M., Swisher E.M., Warrington J.A., King M.C. BRCAl transcriptionally regulates genes involved in breast tumorigenesis Proc Natl Acad Sci U S A 2002. V. 99. P. 7560−7565.
185. Welcsh P.L., Owens K.N., King M. C, Insights into the functions of BRCAl and BRCA2 Trends Genet. 2000. V. 16. P, 69−74.
186. White E. Life, death, and the pursuit of apoptosis Genes Dev, 1996, V, lO.P. 1−15, 128
187. Wittenkeller J.L., Storer В., Bittner G., Schiller J.H. Comparison of spontaneous and induced mutation rates in an immortalized human bronchial epithelial cell line and its tumorigenic derivative Oncology. 1997. V. 54. P. 335−341.
188. Wogan G.N., Hecht S.S., Felton J.S., Conney A.H., Loeb L.A. Environmental and chemical carcinogenesis Semin Cancer Biol. 2004. V. 14. P. 473−486.
189. Wolff M.S., Weston A. Breast cancer risk and environmental exposures Environ Health Perspect. 1997. V. 105. P. 891−896.
190. Wood R.D., Mitchell M., Sgouros J., Lindahl T. Human DNA repair genes Science. 2001. V. 291. P. 1284−1289.
191. Wooster R., Bignell G., Lancaster J., Swift S., Seal S., Mangion J., Collins N., Gregory S., Gumbs C, Micklem G. Identification of the breast cancer susceptibility gene BRCA2 Nature. 1995. V. 378. P. 789−792.
192. Xing D., Qi J., Miao X., Lu W., Tan W., Lin D. Polymorphisms of DNA repair genes XRCCl and XPD and their associations with risk of esophageal squamous cell carcinoma in a Chinese population Int J Cancer. 2002. V. 100. P. 600−605.
193. Xing D.Y., Tan W., Song N., Lin D.X. Ser326Cys polymorphism in hOGGl gene and risk of esophageal cancer in a Chinese population Int. J. Cancer. 2001. V. 95. P. 140−143. 268. Xu J., Zheng S.L., Turner A., Isaacs S.D., Wiley K.H., Hawkins G.A., Chang B.L., Bleecker E.R., Walsh P. C, Meyers D.A., Isaacs W.B. Associations between hOGGl sequence variants and prostate cancer susceptibility Cancer Res. 2002. V. 62. P. 2253−2257. 129
194. Yager J.D., Liehr J.G. Molecular mechanisms of estrogen carcinogenesis Annu Rev Pharmacol Toxicol. 1996. V. 36. P. 203−232.
195. Yager J.D. Endogenous estrogens as carcinogens through metabolic activation J Natl Cancer Inst Monogr. 2000. V. 27. P. 67−73.
196. Yarden R. L, Brody L.C. BRCAl interacts with components of the histone deacetylase complex Proc. Nat. Acad. Sci. 1999. V. 96. P. 49 834 988.
197. Yarden R. L, Pardo-Reoyo S., Sgagias M., Cowan K.H., Brody L.C. BRCAl regulates the G2/M checkpoint by activating Chkl kinase upon DNA damage //Nature Genet. 2002. V. 30. P. 265−269.
198. Yazdi P.T., Wang Y., Zhao S., Patel N., Lee E.Y., Qin J. SMCl is a downstream effector in the ATM/NBSl branch of the human S-phase checkpoint Genes Dev. 2002. V. 16. P. 571−582.
199. Zhang H., Somasundaram K., Peng Y., Tian H., Zhang H., Bi D., Weber B.L., El-Deiry W.S. BRCAl physically associates with p53 and stimulates its transcriptional activity Oncogene. 1998. V. 16. P. 17 131 721.
200. Zheng L., Annab L.A., Afshari C.A., Lee W.H., Boyer T.G. BRCAl mediates ligand-independent transcriptional repression of the estrogen receptor Proc Natl Acad Sci U S A. 2001. V. 98. P. 9587−9592. 130